Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

This study has been completed.
TKL Research, Inc.
Information provided by (Responsible Party):
Peplin Identifier:
First received: June 8, 2009
Last updated: March 25, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2009
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 22, 2010